CanBas Co (TSE:4575) EBIT per Share: 円-50.74 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4575 CanBas Co Ltd TSE:4575
31 GF Score
Price 円796.00
View Full Analysis

What is CanBas Co EBIT per Share?

CanBas Co TSE:4575 +5.99% 31 EBIT per Share is 円-50.74 as of Dec. 2025. GuruFocus rates TSE:4575 with a GF Score™ of 31/100. Among 1,173 Biotechnology companies, CanBas Co ranks worse than 53.96% on this metric.

CanBas Co's EBIT per Share for the three months ended in Dec. 2025 was 円0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was 円-50.74.

During the past 3 years, the average EBIT per Share Growth Rate was 12.50% per year. During the past 5 years, the average EBIT per Share Growth Rate was 5.80% per year. During the past 10 years, the average EBIT per Share Growth Rate was 2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for CanBas Co's EBIT per Share or its related term are showing as below:

TSE:4575' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -49.5   Med: 8   Max: 57.4
Current: 12.5

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of CanBas Co was 57.40% per year. The lowest was -49.50% per year. And the median was 8.00% per year.

TSE:4575's 3-Year EBIT Growth Rate is ranked worse than
53.96% of 1173 companies
in the Biotechnology industry
Industry Median: 15.5 vs TSE:4575: 12.50

CanBas Co's EBIT for the three months ended in Dec. 2025 was 円0.00 Mil.

CanBas Co  (TSE:4575) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

CanBas Co EBIT per Share Related Terms

CanBas Co EBIT per Share Historical Data

* Premium members only.

The historical data trend for CanBas Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CanBas Co EBIT per Share Chart

CanBas Co Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -68.87 -87.61 -82.87 -70.85 -58.59

CanBas Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.56 -16.41 -18.29 0.00 -16.04
TSE:4575
31GF Score
CanBas Co Ltd TSE:4575
EBIT per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CanBas Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

CanBas Co's EBIT per Share for the fiscal year that ended in Jun. 2025 is calculated as

EBIT per Share(A: Jun. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-1109.562/18.939
=-58.59

CanBas Co's EBIT per Share for the quarter that ended in Dec. 2025 is calculated as

EBIT per Share(Q: Dec. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=0/19.703
=0.00

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-50.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of 円-50.74 mean?
CanBas Co (TSE:4575) has a EBIT per Share of 円-50.74 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on CanBas Co and its competitors. According to the industry distribution chart, CanBas Co ranks #633 out of 1173 companies in the Biotechnology industry, placing it in the top 54%.
Is CanBas Co's EBIT per Share too high?
CanBas Co's current EBIT per Share is 円-50.74. Based on the distribution chart, CanBas Co ranks #633 out of 1173 companies in the Biotechnology industry, which is below the industry midpoint. Overall, CanBas Co has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does CanBas Co's EBIT per Share compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CanBas Co ranks #633 out of 1173 companies for EBIT per Share. This places CanBas Co in the lower half of its industry. The industry median EBIT per Share is 15.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Biotechnology company?
The median EBIT per Share among Biotechnology companies is 15.50, based on 1,173 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on CanBas Co and its competitors. For the Biotechnology industry, the median EBIT per Share is 15.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CanBas Co's current EBIT per Share is 円-50.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CanBas Co stock overvalued right now?
CanBas Co (TSE:4575) has a current EBIT per Share of 円-50.74. The current EBIT per Share is 円-50.74. CanBas Co's overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For CanBas Co (TSE:4575), the current EBIT per Share is 円-50.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CanBas Co Business Description

Address 2-2-1 Otemachi, Numazu, Shizuoka, JPN, 410-0891
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.
31GF Score

Get the complete analysis for TSE:4575

EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円796.00
Price